SEARCH RESULTS FOR:
By Land, Sea and Air: Asia-Pacific’s Logistics and Distribution Hub
Singapore Chemicals 2018 Pre-Release
Singapore owes its status as a leading trading hub to its excellence in logistics and continues investing to maintain its lead.
Satvinder Singh
ASSISTANT CHIEF EXECUTIVE OFFICER, ENTERPRISE SINGAPORE
Singapore Chemicals 2018
“With the formation of Enterprise Singapore, our role is to grow stronger Singapore enterprises. Building on the foundation of the two previous organizations, we now have increased and improved resources to be more effective on both the domestic and international fronts.”
Dr. Jim Li
CEO, SUNDIA
Sundia is a CRO based in China and speaks to GBR of the evolution of the drug discovery process in China.
Suresh Vadnagra
EXECUTIVE GENERAL MANAGER OPERATIONS AMERICAS, MMG & PRESIDENT, MINERA LAS BAMBAS
Peru Mining 2018 Pre-Release 2
MMG speaks to GBR about the first year of production at the vast Las Bambas copper mine.
Maurice Mason
VP CORPORATE DEVELOPMENT & INVESTOR RELATIONS, CALEDONIA MINING CORPORATION
Caledonia Mining Corporation speaks about its gold mining activities in Zimbabwe.
Erdem Tüzünalp
REGIONAL GENERAL MANAGER, TURKEY & MENA, EPIROC
"Turkey is still relatively new to mining but there are a lot of reserves and after the privatization drive, the industry grew rapidly. However, we still do not have a high enough level of exploration and there are social and environmental problems, which means it is difficult to get permits."
Jeffrey A Quartermaine
CEO AND Managing Director, PERSEUS MINING
Perseus became a multi-mine, multi-jurisdiction gold producer in January 2018 and persists in its quest to operate three mines in West Africa by 2020.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
